Hennigsdorf (Germany), August 13, 2019 – Adrenomed AG, the vascular integrity company, announced today its participation at four upcoming conferences in Europe. Adrenomed representatives will be available for networking and one-to-one meetings at the
32nd European Society of Intensive Care Medicine (ESICM) LIVES 28 September – 2 October | CityCube, Berlin, Germany Talk: October 1st, 16:20 CET, room Stockholm. “Adrenomedullin in sepsis, effect of the non-inhibitory antibody Adrecizumab”, session “Innovation
European Business Development Conference (EBDC) 25-26 September | Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany Spotlight Talk on Sepsis on the 26th of September, 12:00 CET Speaker: Dr. Frauke Hein, Chief Business Officer Link to the Conference
19th Annual Biotech in Europe Forum (Sachs Conference) 25-26 September | Congress Center Basel, Switzerland Company Presentation on the 25th of September, 10:45 CET Speaker: Dr. Frauke Hein, Chief Business Officer Link to the Conference
Article in BioWorld: Adrenomed readies for success as lead drug adrecizumab clears interim hurdle in sepsis trial
April 2019 by Cormac Sheridan, Staff Writer.
Hennigsdorf (Germany), May 6, 2019 – Adrenomed AG, the vascular integrity company, announced today its participation at three upcoming conferences in Europe and the USA. Adrenomed representatives will be available for one-on-one meetings at